IN VIVO CAR-T FOR MAST-CELL DRIVEN ALLERGIC DISEASES
Misson
Our mission is to fundamentally change how allergic diseases are treated by using in vivo–delivered mRNA CAR-T cells to precisely eliminate mast cells—the root cause of all severe allergic reactions—safely resetting the immune system without permanent alteration.
Our approach targets highly selective markers present on all human mast cells and uses a short-lived message to train the immune system to remove them—resetting allergy responses while immune cells naturally return to normal within days
We are experts in the field of cell and gene therapy, love to collaborate, and are committed to our four core values: Safety | Integrity | Innovation | Excellence